Literature DB >> 29439266

Effect of the Opioid Crisis on the Donor Pool for Kidney Transplantation: An Analysis of National Kidney Deceased Donor Trends from 2010-2016.

Donald F Chute1, Meghan E Sise2.   

Abstract

BACKGROUND: The opioid crisis has led to a dramatic increase in the number of drug overdose deaths in the United States. Little is known about the effect of the opioid crisis on the kidney transplant donor pool, particularly on hepatitis C virus (HCV)-infected donors.
METHODS: This is a retrospective analysis of the data from the Organ Procurement and Transplantation Network from 2010 to 2016. We determined the changes in characteristics of kidney transplant donors and evaluated which changes may be directly related to the opioid crisis.
RESULTS: Between 2010 and 2016, we found a 26% increase in overall donors, including a 277% increase in the number of donors who died from drug overdose. Nineteen percent of donors who died of drug overdose had HCV infection. Donors who die from drug overdose and donors with HCV infection are younger, less likely to have diabetes or hypertension, and have favorable kidney donor profile index scores compared to average donors. Despite these favorable characteristics, HCV-infected donors appear to be notably underutilized, with substantially lower kidneys per donor being transplanted compared to HCV uninfected donors.
CONCLUSION: The opioid crisis in the United States has substantially altered the kidney donor pool. Strategies to increase utilization of all potentially viable kidneys for transplant are needed, particularly in this era of new, highly effective, direct-acting antiviral therapy for HCV infection.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Drug overdose; Hepatitis C virus; Kidney transplant

Mesh:

Year:  2018        PMID: 29439266     DOI: 10.1159/000486516

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  12 in total

1.  Patient's Perspectives of Experimental HCV-Positive to HCV-Negative Renal Transplantation: Report from a Single Site.

Authors:  Sarah E Van Pilsum Rasmussen; Shanti Seaman; Diane Brown; Niraj Desai; Mark Sulkowski; Dorry L Segev; Christine M Durand; Jeremy Sugarman
Journal:  AJOB Empir Bioeth       Date:  2019-10-16

2.  Hepatitis C virus infection and the kidney.

Authors:  Meghan E Sise
Journal:  Nephrol Dial Transplant       Date:  2018-07-27       Impact factor: 5.992

3.  HCV-Infected Deceased Donor Kidney Transplantation-Time to Take Up the Offer.

Authors:  Yuvaram N V Reddy; Krishna P Reddy; Meghan E Sise
Journal:  Am J Kidney Dis       Date:  2020-04-18       Impact factor: 8.860

Review 4.  Balancing the risk and rewards of utilizing organs from hepatitis C viremic donors.

Authors:  Meghan E Sise; Ian A Strohbehn; Emily Bethea; Jenna L Gustafson; Raymond T Chung
Journal:  Curr Opin Organ Transplant       Date:  2019-06       Impact factor: 2.640

Review 5.  Curative Therapies for Hepatitis C Virus Infection in Patients with Kidney Disease.

Authors:  Ian A Strohbehn; Rituvanthikaa Seethapathy; Meghan Lee; Meghan E Sise
Journal:  Kidney360       Date:  2021-05-21

6.  Efficacy and Safety of Direct-Acting Antivirals in Kidney Transplantation From HCV-Viremic Donors to Negative Recipients: A Meta-Analysis.

Authors:  Zepei Feng; Jinwei Zhang; Weilong Tan; Chunhui Wang; Qiong Chen; Chao Shen; Haozhi Fan; Yun Zhang; Peng Huang; Ming Yue
Journal:  Front Med (Lausanne)       Date:  2022-05-18

7.  Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection.

Authors:  Meghan E Sise; David S Goldberg; Jens J Kort; Douglas E Schaubel; Rita R Alloway; Christine M Durand; Robert J Fontana; Robert S Brown; John J Friedewald; Stacey Prenner; J Richard Landis; Melissa Fernando; Caitlin C Phillips; E Steve Woodle; Adele Rike-Shields; Kenneth E Sherman; Nahel Elias; Winfred W Williams; Jenna L Gustafson; Niraj M Desai; Brittany Barnaba; Silas P Norman; Mona Doshi; Samuel T Sultan; Meredith J Aull; Josh Levitsky; Dianne S Belshe; Raymond T Chung; Peter P Reese
Journal:  J Am Soc Nephrol       Date:  2020-08-25       Impact factor: 10.121

Review 8.  Opioids and Kidney Transplantation.

Authors:  Marie-Camille Lafargue; Yasar Caliskan; Krista L Lentine; Leonardo V Riella
Journal:  Semin Nephrol       Date:  2021-01       Impact factor: 5.299

9.  Facilitating Patient-Centered Decision Making Around the Timing of Direct-Acting Antivirals in Patients With Hepatitis C Virus and CKD.

Authors:  Meaghan Roche; Deirdre L Sawinski; Jordana B Cohen
Journal:  Kidney Med       Date:  2019-07-13

10.  Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era.

Authors:  Andrew A Li; George Cholankeril; Xingxing S Cheng; Jane C Tan; Donghee Kim; Alice E Toll; Satheesh Nair; Aijaz Ahmed
Journal:  Diseases       Date:  2018-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.